Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer

Author:

Farmer Emily,Cheng Max A.,Hung Chien-Fu,Wu T.-C.

Publisher

Springer International Publishing

Reference126 articles.

1. Ahn YH, Hong SO, Kim JH, Noh KH, Song KH, Lee YH, Jeon JH, Kim DW, Seo JH, Kim TW (2015) The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-beta receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity. Clin Exp Immunol 181(1):164–178. Epub 2015/03/11. https://doi.org/10.1111/cei.12620. PubMed PMID: 25753156; PMCID: PMC4469167

2. Alvarez RD, Huh WK, Bae S, Lamb LS, Jr., Conner MG, Boyer J, Wang C, Hung CF, Sauter E, Paradis M, Adams EA, Hester S, Jackson BE, Wu TC, Trimble CL (2016) A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3). Gynecol Oncol 140(2):245–252. Epub 2015/12/01. https://doi.org/10.1016/j.ygyno.2015.11.026. PubMed PMID: 26616223; PMCID: PMC4724445

3. American Cancer Society (2018) Can oral cavity and oropharyngeal cancers be found early? Available from https://www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/detection-diagnosis-staging/detection.html. Updated 9 Mar 2018; Cited 2019

4. Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC (2003) Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res 9(14):5205–5213 Epub 2003/11/14 PubMed PMID: 14614000

5. Barra F, Maggiore ULR, Bogani G, Ditto A, Signorelli M, Martinelli F, Chiappa V, Lorusso D, Raspagliesi F, Ferrero S (2019) New prophylactics human papilloma virus (HPV) vaccines against cervical cancer. J Obstet Gynaecol 39(1):1–10. Epub 2018/10/30. https://doi.org/10.1080/01443615.2018.1493441. PubMed PMID: 30370796

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3